Intuitive Surgical stock slips 4.61% from November 5 report

Intuitive Surgical stock moved materially lower than in the latest relevant report, giving investors a fresh market signal after the company's third-quarter update. The comparison is based on the Lang & Schwarz quote in the November 5 report and the latest quote on Friday, November 6.

The stock traded at 410.88 euros on Lang & Schwarz at 16:35 CET on Friday, November 6. That was 4.61 percent below the 430.75-euro quote recorded at 14:32 CET on Thursday, November 5, in the previous report. This change since the report is separate from a Xetra daily comparison.

Business remains tied to robotic surgery

Intuitive Surgical's investor overview describes the company as a global technology leader in robotic-assisted, minimally invasive surgery. It develops, manufactures and markets the da Vinci surgical system.

The investor page lists Intuitive's third-quarter earnings release from October 20, 2026. The latest report highlighted strong procedure growth alongside legal uncertainty and said management kept its 2026 procedure outlook in focus.

What the move means for investors

The latest decline increases the importance of execution against the company's growth targets and the market's assessment of legal and cost risks. A single trading move does not establish why the stock changed, but it raises the sensitivity of the valuation to upcoming operating updates.

Broader conditions for US healthcare technology stocks remain relevant; see current S&P 500 market coverage.

For the real-time quote of Intuitive Surgical stock, investors can follow the latest market indication. More news and analyses on Intuitive Surgical stock provide further company coverage.

Intuitive Surgical at a glance

• Company: Intuitive Surgical, Inc.
• ISIN: US46120E6023
• Ticker: ISRG
• Home exchange: Nasdaq Global Select Market
• Lang & Schwarz price: 410.88 euros at 16:35 CET on November 6, 2026
• Change since November 5 report: Down 4.61 percent from 430.75 euros